Genenta Science SpA ADR
Quarterly Financials
| Values in thousands | 2023-12-31 | 2023-06-30 |
|---|---|---|
Gross Profit | -20 | -20 |
EBITDA | -2 | -3 |
EBIT | -2 | -24 |
Net Income | -2 | -6,696 |
Free Cash Flow | -1 | -7,521 |
Cash | 3,691 | 12,213 |
Basic Shares | 18 | 18,216 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -41 | -6 | -5 | -1 |
EBITDA | -11,690 | -11,037 | -5,682 | -5,588 |
EBIT | -11,732 | -11,043 | -5,687 | -5,590 |
Net Income | -11,645 | -3,624 | -5,560 | -5,605 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -11,218 | -7,445 | -6,967 | -6,065 |
Cash | 3,691 | 29,794 | 37,240 | 15,465 |
Basic Shares | 18,216 | 18,216 | 18,216 | 18,120 |
Earnings Calls
| Quarter | EPS |
|---|---|
2021-03-31 | -$0.16 |
2020-12-31 | -$0.16 |
2020-09-30 | -$0.12 |
2020-06-30 | -$0.12 |
